| Title |
Author |
Type |
Date |
Words |
| Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs. |
|
|
May 9, 2013 |
1277 |
| Alnylam and Tekmira Restructure Relationship and Settle All Litigation. |
|
|
Nov 13, 2012 |
1728 |
| LabCorp Enters Into License Agreement with Sequella for use of B-SMART[TM] Technology to develop Rapid Tuberculosis Antimicrobial Susceptibility Test. |
|
|
Oct 22, 2012 |
533 |
| Canada : Abattis signs LOI to purchase Bio-Pharma license and equipment from Vertical Design Systems Ltd. |
|
|
Oct 19, 2012 |
240 |
| Japan : Astellas Enters License Agreement with Janssen to Develop and Commercialize ASP015K, an Astellas' Oral JAK Inhibitor for Immunologic Diseases. |
|
|
Oct 3, 2012 |
309 |
| Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion. |
|
|
Sep 12, 2012 |
417 |
| PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). |
|
|
Jul 9, 2012 |
421 |
| PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). |
|
|
Jul 9, 2012 |
427 |
| Retinalyze, LLC Signs Licensing Agreement for Vision Plan Reimbursement. |
|
|
Jun 20, 2012 |
991 |
| GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics. |
|
|
May 31, 2012 |
1095 |
| Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent. |
|
|
May 23, 2012 |
1456 |
| Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals. |
|
|
May 14, 2012 |
426 |
| Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic. |
|
|
May 7, 2012 |
531 |
| Dyadic International Expands License Agreement With Abengoa. |
|
|
May 1, 2012 |
629 |
| IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand. |
|
|
Apr 10, 2012 |
638 |
| Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004. |
|
|
Mar 6, 2012 |
765 |
| Roche and Life Technologies Corporation Sign New PCR IVD Licenses. |
|
|
Feb 22, 2012 |
460 |
| NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement With Health Discovery Corporation. |
|
|
Jan 9, 2012 |
930 |
| Health Discovery Corporation Enters into Worldwide Licensing Agreement with NeoGenomics. |
|
|
Jan 9, 2012 |
968 |
| Alnylam and Arrowhead Form Collaboration and Licensing Agreement. |
|
|
Jan 5, 2012 |
1892 |
| Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765. |
|
|
Dec 8, 2011 |
727 |
| Affymetrix Completes Strategic Licensing Agreement with Genisphere for Proprietary MicroRNA Reagents. |
|
|
Nov 17, 2011 |
791 |
| Daiichi Sankyo To License ARQ 092 from ArQule, the First New Compound Resulting from the Companies' Joint AKIP Research Collaboration. |
|
|
Nov 10, 2011 |
1128 |
| Blaze Bioscience Licenses Tumor Paint Technology from Fred Hutchinson Cancer Research Center. |
|
|
Oct 18, 2011 |
446 |
| Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor. |
|
|
Oct 5, 2011 |
827 |
| Sequenom signs European Licensing Pact With LifeCodexx. |
|
|
Aug 30, 2011 |
539 |
| Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement. |
|
|
Aug 24, 2011 |
496 |
| TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation. |
|
|
Jul 28, 2011 |
584 |
| CSL Limited Signs Commercial License Agreement with Selexis SA. |
|
|
Jul 26, 2011 |
503 |
| Cannabis Science Signs A New Non-Exclusive Commercial License Agreement with Rockbrook To Continue Its Strategic Partnership In The State Of Colorado. |
|
|
Jul 12, 2011 |
480 |
| Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry. |
|
|
Jun 27, 2011 |
697 |
| Generex Announces Intention to Dividend a Portion of Anticipated Amarantus BioSciences Shares to Its Shareholders upon a Reverse Stock Split. |
|
|
Jun 1, 2011 |
1444 |
| AVEO Pharmaceuticals Enters into Worldwide License Agreement with Centocor Ortho Biotech to Develop and Commercialize RON-Targeted Antibodies. |
|
|
May 31, 2011 |
1063 |
| Avjet Biotech Signs License Agreement with NC State to Commercialize Aviation Biofuel Technologies. |
|
|
Apr 21, 2011 |
489 |
| Biotechnology company Xoma Ltd (Berkeley CA) said it signed a development and licensing deal with Les Laboratoires Servier (Neuilly-sur-Seine FRA) potentially worth more than $500 million for an anti-inflammatory drug candidate. |
|
|
Jan 10, 2011 |
200 |
| Idaho Technology and Bio-Rad Sign License Agreement. |
|
|
Dec 21, 2010 |
205 |
| Metamark and HistoRx Announce Licensing Agreement for AQUA Technology. |
|
|
Dec 20, 2010 |
603 |
| Epigenomics and Predictive Biosciences Extend Licensing Deal for Prostate Cancer Test. |
|
|
Nov 16, 2010 |
814 |
| Life Technologies Signs Exclusive License Agreement for DNA Error-Correction Technology from Novici Biotech LLC. |
|
|
Oct 11, 2010 |
864 |
| Research and Markets: Royalty Rates in Biotech: a BVR's Guide to Full-Text Licensing Agreements. |
|
|
Oct 6, 2010 |
257 |
| SP Scientific Signs License Agreement for Praxair's ControLyo[TM] Nucleation Technology. |
|
|
Sep 29, 2010 |
480 |
| Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement. |
|
|
Sep 27, 2010 |
577 |
| Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement. |
|
|
Sep 27, 2010 |
646 |
| BVR Announces New Reference Guides for Licensing and Intellectual Property. |
|
|
Sep 23, 2010 |
478 |
| TriLink BioTechnologies, Inc. Announces License Agreement with Biofortuna Ltd. |
|
|
Sep 14, 2010 |
801 |
| Asklepios BioPharmaceutical Enters Into A Patent License Agreement With Pfizer. |
|
|
Sep 13, 2010 |
284 |
| Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. |
|
Conference news |
Aug 26, 2010 |
476 |
| Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. |
|
Conference news |
Aug 26, 2010 |
632 |
| Research and Markets: Pharmaceutical Licensing Overview - Includes Assessment of Drug Discovery & Technology Deals Made by the Top 10 Pharma Companies. |
|
|
Aug 11, 2010 |
489 |
| Idaho Technology Issues License to DuPont Qualicon. |
|
|
Jul 30, 2010 |
259 |
| NovImmune Enters Exclusive Antibody Licensing Agreement with Genentech. |
|
|
Jul 26, 2010 |
459 |
| OvaGene Oncology Licenses Gene-Based Technologies to Develop Novel Endometrial and Cervical Cancer Assays. |
|
|
Jul 12, 2010 |
921 |
| MRC Technology Enters Into an Exclusive License Agreement With Genentech. |
|
|
Jul 11, 2010 |
768 |
| MRC Technology Enters Into an Exclusive License Agreement With Genentech. |
|
|
Jul 11, 2010 |
773 |
| Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM(TM) Targets to Treat Autoimmune Diseases. |
|
|
Jul 8, 2010 |
740 |
| MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program. |
|
|
Jun 28, 2010 |
1041 |
| LILLY (ELI) & COMPANY - Marcadia - Lilly Novel Glucagon Program. |
|
|
Jun 28, 2010 |
583 |
| International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement. |
|
|
Jun 24, 2010 |
542 |
| ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Target. |
|
|
Jun 22, 2010 |
692 |
| Advaxis and the University of Pennsylvania Reach Agreement. |
|
|
May 18, 2010 |
460 |
| 'Less is more' with the innovation of Avemar Fermented Wheat Germ Extract. |
|
|
May 1, 2010 |
536 |
| Bicycle Therapeutics Signs License Agreement with EPFL and Adds SR One and SVLS to Seed Syndicate. |
|
|
Apr 29, 2010 |
727 |
| Astra paying over $2 billion for Rigel arthritis drug. AstraZeneca Plc. |
|
|
Feb 22, 2010 |
394 |
| Trillium and Biogen Idec Enter Into Global License Agreement. |
|
|
Jan 12, 2010 |
506 |
| Syntiron LLC Enters Collaborative Development and Licensing Agreement with sanofi pasteur to Develop Its Prophylactic Vaccine against Staphylococcus aureus. |
|
|
Dec 16, 2009 |
573 |
| Idaho Technology Issues License to Kapa Biosystems, Inc. |
|
Company overview |
Dec 15, 2009 |
300 |
| EraGen Announces a Strategic Partnership, Licensing Agreement with Illumina. |
|
|
Nov 18, 2009 |
378 |
| Dow AgroSciences, Chromatin Announce Research, License Agreements. |
|
|
Nov 11, 2009 |
559 |
| Ligand Updates License Agreement with Exelixis. |
|
|
Nov 2, 2009 |
537 |
| Celera Licenses Lung Cancer Intellectual Property from Medical Therapies. |
|
|
Oct 29, 2009 |
943 |
| ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009. |
|
|
Sep 11, 2009 |
789 |
| Scarab Genomics and NeoClone Have Entered Into License Agreement for Antibodies Against Shiga Toxin. |
|
|
Sep 10, 2009 |
167 |
| DEBIOPHARM/MERCURY SIGN LICENSE AGREEMENT FOR DEBIO 0930. |
|
|
Sep 1, 2009 |
626 |
| Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain. |
|
|
Aug 26, 2009 |
699 |
| Biosystems International Establishes Licensing Agreement with Lohocla Research Institute to Search for Novel Alcoholism Liver Disease Biomarkers. |
|
|
Jun 11, 2009 |
441 |
| Exelixis and Sanofi-aventis Sign Global License Agreement for XL147 & XL765 and Launch Broad Collaboration for Discovery of PI3K Inhibitors. |
|
|
May 28, 2009 |
1121 |
| Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd. |
|
|
May 26, 2009 |
485 |
| Dyadic International and Abengoa Bioenergy New Technologies Settle Litigation and Enter into License Agreement for the Production of Cellulosic Ethanol. |
|
|
May 13, 2009 |
493 |
| Idaho Technology Issues License to Finnzymes. |
|
|
May 12, 2009 |
297 |
| Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin. |
|
|
May 4, 2009 |
1032 |
| ITI achieves major milestone with first license. |
|
Brief article |
May 1, 2009 |
267 |
| Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen. |
|
|
Apr 23, 2009 |
922 |
| Genzyme Corp. |
|
Brief article |
Apr 6, 2009 |
233 |
| Idaho Technology Issues License to Thermo Fisher Scientific. |
|
|
Mar 31, 2009 |
235 |
| PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies. |
|
|
Feb 24, 2009 |
404 |
| Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test. |
|
|
Feb 1, 2009 |
761 |
| Merck KGAA. |
|
Brief article |
Jan 19, 2009 |
154 |
| ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell. |
|
|
Jan 13, 2009 |
479 |
| Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for Thermodox[R] with Yakult Honsha. |
|
|
Dec 16, 2008 |
795 |
| Pressure BioSciences and Battelle Sign Exclusive Protein Analysis Patent License Agreement. |
|
|
Dec 1, 2008 |
692 |
| Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA. |
|
|
Oct 30, 2008 |
937 |
| Xenomics Announces License Agreement with Sequenom for Prenatal Diagnostic Applications of Transrenal Nucleic Acid Technology. |
|
|
Oct 30, 2008 |
567 |
| Nanogen Extends Celera License Agreement for Additional IVD Products. |
|
|
Oct 23, 2008 |
384 |
| Moraga Announces Licensing Agreement with Pharmacells, Ltd. |
|
|
Oct 8, 2008 |
269 |
| Kuros and Aeris Announce Exclusive License Agreement in the Field of Lung Volume Reduction. |
|
|
Sep 23, 2008 |
651 |
| Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents. |
|
|
Sep 22, 2008 |
1138 |
| Can-Fite Signs MOU With the Korean Company Kwang Dong Pharmaceutical for Licensing CF101 Rights for Korea. |
|
|
Sep 9, 2008 |
431 |
| Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease. |
|
|
Sep 3, 2008 |
1372 |
| Smart Personalized Medicine, LLC, Founded by Dr. Richard Caruso, Signs Agreement with Health Discovery Corporation to Work to Develop New Breast Cancer Prognostic Test. |
|
|
Aug 29, 2008 |
498 |
| GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin. |
|
|
Aug 6, 2008 |
392 |
| Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells. |
|
|
May 8, 2008 |
615 |
| Roche Diagnostics Licenses the Technology Used for the LightCycler(R) System to BIOTECON. |
|
|
Apr 29, 2008 |
506 |
| Codon Devices and Merrimack Pharmaceuticals Enter Into Research, Development and License Agreement. |
|
|
Apr 16, 2008 |
482 |
| Roche NimbleGen and Affymetrix Expand Licensing Agreement. |
|
Company overview |
Mar 13, 2008 |
383 |
| BioWa Announces Expansion of License Agreement with Genentech for BioWa's POTELLIGENT(R) Technology. |
|
|
Mar 3, 2008 |
394 |
| Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V. |
|
|
Feb 29, 2008 |
612 |
| Nara Biosciences Inc. Completes Exclusive Licensing Agreement with Boston University for Metabolic and Muscle Wasting Disorder Therapies Discovered in the MyoMouse. |
|
|
Feb 6, 2008 |
347 |
| Nara Biosciences Inc. Inks License Agreement for MyoMouse Platform. |
|
|
Feb 6, 2008 |
311 |
| ArQule Receives Payment for Initiation of ARQ 197 Trial in Japan. |
|
|
Feb 6, 2008 |
366 |
| Invitrogen Enters Non-Coding RNA Licensing Agreement with IMBcom. |
|
|
Jan 17, 2008 |
758 |
| Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme. |
|
|
Jan 7, 2008 |
938 |
| Bard to License Hernia Product and Technology from Genzyme Corporation. |
|
|
Dec 17, 2007 |
449 |
| Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents. |
|
|
Nov 20, 2007 |
1037 |
| GPC Biotech Announces Favorable Ruling in Arbitration with Spectrum Pharmaceuticals. |
|
|
Nov 6, 2007 |
732 |
| Rosetta selects PCR as platform for its microRNA-based diagnostics to be launched in 2008. |
|
|
Nov 1, 2007 |
418 |
| Amicus and Shire enter Into $440 million ex-US licensing agreement to develop and commercialize lysosomal storage disorder technology. |
|
|
Oct 1, 2007 |
965 |
| Clinical Data Announces License Agreement With Victorian Clinical Genetics Services Ltd. |
|
|
Oct 1, 2007 |
948 |
| RXi Pharmaceuticals Licenses RNA Chemistry Technologies from TriLink Biotechnologies. |
|
|
Sep 10, 2007 |
757 |
| Affymetrix and Empire Genomics Enter Into Licensing Agreement. |
|
|
Sep 7, 2007 |
656 |
| Abraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in India. |
|
|
Aug 9, 2007 |
552 |
| Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin. |
|
|
Aug 9, 2007 |
887 |
| Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union. |
|
|
Jul 19, 2007 |
768 |
| Clarient and Health Discovery initiate alliance with licensing agreement for new molecular diagnostic test for prostate cancer. |
|
Company overview |
Jul 1, 2007 |
809 |
| ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE. |
|
|
Jun 1, 2007 |
654 |
| Advanced Cell Technology and Wisconsin Alumni Research Foundation Announce Commercial License Agreement. |
|
|
May 2, 2007 |
655 |
| Martek signs license and supply agreement. |
|
Brief article |
May 1, 2007 |
118 |
| Arcadia Biosciences And SESVanderHave Seeds Enter Research and Commercial License Agreement for Development of Nitrogen Use Efficient Sugar Beets. |
|
|
Apr 26, 2007 |
503 |
| Thrombogenics Announces License Agreement With Millipore for Commercialization of Stem Cell Medium Technology. |
|
|
Apr 16, 2007 |
873 |
| Affitech Signs License Agreement for Single-Chain Antibody Technology with Micromet. |
|
|
Mar 28, 2007 |
392 |
| Pluristem Life Systems, Inc. Announces First Licensing Agreement and Stock Swap With Stem Cell Innovations, Inc. |
|
|
Feb 22, 2007 |
1226 |
| Valeant Pharmaceuticals & Metabasis Therapeutics Close Licensing Deal with Schering-Plough Corporation. |
|
|
Jan 11, 2007 |
220 |
| Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40. |
|
|
Jan 8, 2007 |
1075 |
| IGI and Novavax enter into license agreement. |
|
|
Jan 5, 2007 |
446 |
| Spectrum Pharmaceuticals Files Arbitration Claim Against GPC Biotech AG for Violations of Satraplatin License Agreement. |
|
|
Dec 14, 2006 |
819 |
| Sangamo BioSciences and City of Hope Announce License Agreement and Research Collaboration to Develop Treatment for Brain Cancer. |
|
|
Dec 12, 2006 |
1623 |
| Health Discovery Corporation Announces Worldwide License Agreement with Pfizer. |
|
|
Dec 11, 2006 |
364 |
| ThromboGenics Announces License Agreement With Bharat Biotech for Novel Thrombolytic Agent. |
|
|
Dec 7, 2006 |
1109 |
| ThromboGenics Announces License Agreement With Bharat Biotech for Novel Thrombolytic Agent. |
|
|
Dec 7, 2006 |
1107 |
| Affymetrix and Baylor College of Medicine Enter into Licensing Agreement. |
|
|
Dec 5, 2006 |
651 |
| Martek, mission Pharmacal sign supply agreement. |
|
Brief article |
Dec 1, 2006 |
99 |
| Schering-Plough licenses worldwide rights to pradefovir, oral hepatitis B treatment in development with Valeant and Metabasis. |
|
|
Dec 1, 2006 |
524 |
| Archemix Grants Ribomic a License to its Intellectual Property to Develop and Commercialize Aptamer-Based Reagents. |
|
|
Nov 29, 2006 |
568 |
| RaySearch Laboratories: Nucletron and RaySearch Have Entered into a Development and License Agreement Regarding Treatment Planning for Proton Therapy in Cancer Treatment. |
|
|
Nov 16, 2006 |
677 |
| Memry Corporation Announces Worldwide Licensing Agreement for Nitinol Stent Coatings. |
|
|
Nov 7, 2006 |
737 |
| Martek, WhiteWave sign agreement. |
|
Brief article |
Nov 1, 2006 |
127 |
| Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with Centocor Research and Development, Inc. |
|
|
Oct 11, 2006 |
269 |
| Affymetrix and NimbleGen Systems Enter into Licensing Agreement. |
|
|
Oct 6, 2006 |
711 |
| Asklepios Biopharmaceutical, Inc. Announces Cross License with GlaxoSmithKline. |
|
|
Sep 28, 2006 |
460 |
| Health Discovery Corporation Announces Worldwide Licensing Agreement with Epigenomics AG. |
|
|
Sep 19, 2006 |
535 |
| Lux Biosciences gains exclusive worldwide license for ophthalmic polyarylate patent estate from Rutgers. |
|
|
Sep 1, 2006 |
858 |
| Neurologix Signs Strategic License Agreement for Component of Its Parkinson's Gene Therapy Product. |
|
|
Aug 7, 2006 |
1078 |
| Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement with Bruker Daltonics. |
|
|
Aug 1, 2006 |
785 |
| Ryogen licenses human aminopeptidase P gene patent to OriGene. |
|
|
Aug 1, 2006 |
360 |
| Pharsight Signs Sixth DMX(R) License Agreement. |
|
|
Jul 10, 2006 |
620 |
| Celera Genomics and Specialty Laboratories Announce Licensing Agreement for Commercialization of Cirrhosis Testing; Genetic Testing Could Be a Better Predictor for High Risk HCV Infected Individuals Than Current Clinical Factors. |
|
|
Jun 22, 2006 |
1602 |
| Affymetrix and Invitrogen Enter Into Licensing Agreement. |
|
|
Jun 21, 2006 |
625 |
| Advanced BioNutrition Corp. |
|
Brief article |
Jun 1, 2006 |
115 |
| BioActives Corporation. |
|
Brief article |
Jun 1, 2006 |
107 |
| Lux Biosciences Raises $36 Million in Series A Financing and Signs Agreement for Advanced Clinical Stage Product. |
|
|
May 25, 2006 |
800 |
| Dyax Corp. and ICOS Corporation Enter Into License Agreement for Discovery of Therapeutic Antibodies. |
|
|
May 22, 2006 |
696 |
| Surge in Strategic Alliances and Licensing Deals to Boost Productivity of Pharmaceutical Companies. |
|
|
May 10, 2006 |
960 |
| Ciba Specialty Chemicals forms JV with Biosignal. |
|
Brief article |
May 1, 2006 |
99 |
| Ingenuity Systems Expands Scope of Licensing Agreement with Daiichi Pharmaceutical Co., Ltd. |
|
|
Apr 25, 2006 |
314 |
| Signature Genomic Laboratories, LLC(R) and Affymetrix, Inc. Sign License Agreement. |
|
|
Feb 14, 2006 |
614 |
| Fisher Biosciences unit, Cellomics, and Evotec Technologies Sign License Agreement; Companies to Collaborate on Cell-Biology Solutions for Life-Science Markets. |
|
|
Jan 30, 2006 |
609 |
| MethylGene and Pharmion Announce North America, E.U. and International Licensing Agreement for Oncology Oral HDAC Inhibitors, Including MGCD0103. |
|
|
Jan 30, 2006 |
2021 |
| Pharmion and MethylGene Announce North America, E.U. and International Licensing Agreement for Oncology Oral HDAC Inhibitors, Including MGCD0103. |
|
|
Jan 30, 2006 |
2095 |
| Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with ImClone Systems. |
|
|
Jan 10, 2006 |
319 |
| Commonwealth Biotechnologies, Inc. and Prism Pharmaceuticals, Inc. Enter into License Agreement to Develop Helix-Based Peptide Technologies. |
|
|
Jan 5, 2006 |
663 |
| Bioheart and Cleveland Clinic sign major patent licensing agreement. |
|
|
Jan 1, 2006 |
844 |
| Affymetrix and Applied Biosystems Enter into Licensing Agreement. |
|
|
Dec 22, 2005 |
1137 |
| Bio-tech firm sells off rights to product. |
|
|
Dec 9, 2005 |
335 |
| Stem Cell Sciences KK signs agreement with the University of Nice to commercialize stem cell therapy for degenerative disease. |
|
Brief Article |
Nov 30, 2005 |
238 |
| DiagnoCure signs license agreement with Genzyme for lung cancer associated genes. |
|
|
Nov 2, 2005 |
613 |
| Clarient and Health Discovery Corporation announce bioinformatics patent licensing agreement. |
|
|
Nov 1, 2005 |
908 |
| Nanogen issued patent for technology enabling assay development to detect difficult nucleic acid sequences. |
|
|
Nov 1, 2005 |
359 |
| Meristem obtains United States patent. |
|
Brief Article |
Nov 1, 2005 |
97 |
| CRYO-CELL Signs Exclusive License to Market New Stem Cell Service. |
|
|
Oct 17, 2005 |
1620 |
| Genzyme signs licensing agreement with UCLA cancer center to develop CML markers. |
|
|
Oct 15, 2005 |
307 |
| Agensys Signs Collaborative Research and License Agreement With sanofi pasteur. |
|
|
Oct 10, 2005 |
533 |
| CRYO-CELL signs exclusive license to market new stem cell service. |
|
Company Profile |
Oct 1, 2005 |
1021 |
| Stem Cell Therapy signs exclusive license agreement with Institute of Cell Therapy for supply of stem cells. |
|
|
Sep 30, 2005 |
257 |
| InsectiGen enters licensing arrangement with Pioneer Hi-Bred. |
|
|
Aug 1, 2005 |
618 |
| Agilent signals diagnostic plans for lab-on-a-chip. |
|
Brief Article |
Jul 15, 2005 |
161 |
| Corautus announces collaboration and licensing agreement for treatment of diabetic neuropathy with VEGF-2. |
|
|
Jul 1, 2005 |
660 |
| Lifebank Cryogenics, University of Alberta sign technology license agreement to pursue new clinical standard for stem cells. |
|
Brief Article |
May 23, 2005 |
223 |
| CryoLife's cryopreserved orthopaedic tissues utilizing Clearant process implanted into human for first time. |
|
Brief Article |
May 13, 2005 |
140 |
| Affymetrix licenses microfluidics technology from Caliper. |
|
|
Apr 1, 2005 |
546 |
| Cimab, Chinese firm sign biotech deal. |
|
Brief Article |
Jan 1, 2005 |
226 |
| Genelabs Technologies receives $1.25 Million from Affymetrix for amendment to non-exclusive license for DNA amplification technology. |
|
|
Dec 1, 2004 |
368 |
| Affymetrix agreement gives Veridex non-exclusive rights to GeneChip technology. |
|
|
Dec 1, 2004 |
289 |
| Roche renews internal research license for patented gene targeting technology from Lexicon. |
|
Brief Article |
Dec 1, 2004 |
253 |
| Corgentech licenses peptide delivery system from Cyclacel. |
|
|
Sep 1, 2004 |
538 |
| Bionomics licenses epilepsy test. |
|
|
Sep 1, 2004 |
696 |
| Kereos and Dow sign licensing agreement for targeted imaging agents. |
|
|
Sep 1, 2004 |
558 |
| AspenBio signs exclusive license with Washington University for reproductive patent estate. |
|
|
Jun 1, 2004 |
575 |
| Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. |
|
|
Jun 1, 2004 |
672 |
| Juvaris Biotherapeutics announces licensing agreement for therapeutic vaccine platform. |
|
|
May 1, 2004 |
565 |
| Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. |
|
|
May 1, 2004 |
693 |
| Geron grants XenoTrans license for nuclear transfer technology to produce transgenic pigs. |
|
Brief Article |
Apr 30, 2004 |
171 |
| fqubed concludes technology licensing agreement with Pharmacopeia. |
|
|
Apr 1, 2004 |
619 |
| Affymetrix announces expanded genomic technologies licensing program. |
|
|
Apr 1, 2004 |
425 |
| DOV Pharmaceutical reorganizes indiplon license. |
|
|
Mar 1, 2004 |
490 |
| Alnylam and Cenix enter into RNAi research service agreement. |
|
|
Feb 1, 2004 |
640 |
| Adenoviral vector patent issued to University of Texas. |
|
|
Jan 1, 2004 |
382 |
| Therion Biologics obtains rights to Biogen Idec LFA-3. |
|
|
Jan 1, 2004 |
389 |
| Protiveris acquires license for Oak Ridge National Laboratory. |
|
|
Jan 1, 2004 |
417 |
| Agenix and Biosite enter into license for D-dimer. |
|
|
Dec 1, 2003 |
600 |
| Lexicon Genetics grants license to AstraZeneca. |
|
|
Dec 1, 2003 |
368 |
| Human Genome Sciences licenses gene sequences to Pfizer. |
|
Brief Article |
Dec 1, 2003 |
103 |
| diaDexus forms diagnostic license agreements with Human Genome Sciences. |
|
Brief Article |
Oct 1, 2003 |
218 |
| Immune Response licenses Hybridon's AMPLIVAX vaccine adjuvant. |
|
|
Oct 1, 2003 |
656 |
| Cambridge Antibody and Dyax amend antibody product agreement. |
|
|
Sep 1, 2003 |
552 |
| Primagen and University of British Columbia enter mitochondrial DNA licensing agreement detection. |
|
|
Sep 1, 2003 |
365 |
| EntreMed announces gene target delivery licensing deal with Oxford BioMedica. |
|
|
Sep 1, 2003 |
585 |
| Amgen and Biovitrum sign metobolic disease license agreement. |
|
|
Sep 1, 2003 |
599 |
| Genzyme Genetics licenses colon cancer diagnostic. |
|
|
Sep 1, 2003 |
572 |
| Cambridge Antibody announces therapeutic antibody licence agreement with Micromet. |
|
|
Sep 1, 2003 |
555 |
| United States company to sell nutraceutical cancer care business. |
|
|
Aug 1, 2003 |
799 |
| Agenix secures diagnostic licenses from Abbott. |
|
|
Aug 1, 2003 |
355 |
| 454 Life Sciences obtains exclusive license from Pyrosequencing. |
|
|
Aug 1, 2003 |
908 |
| ViaCell obtains worldwide exclusive license to patented oocyte cryopreservation technique. |
|
|
Aug 1, 2003 |
640 |
| Human Genome Sciences licenses human gene technology to Genentech. |
|
Brief Article |
Aug 1, 2003 |
233 |
| Human Genome Sciences acquires CCR5 receptor license from Abgenix. |
|
|
May 1, 2003 |
528 |
| Introgen licenses fus1 gene from University of Texas. |
|
|
May 1, 2003 |
476 |
| Introgen gains exclusive license to anti-cancer gene. |
|
|
Apr 1, 2003 |
476 |
| Lexicon Genetics licenses patented gene targeting technology. |
|
Brief Article |
Apr 1, 2003 |
201 |
| Angiotech broadens alliance with Baxter to include surgical sealant. |
|
|
Apr 1, 2003 |
297 |
| Genetic Technologies grants non-coding license to Pathologists. |
|
|
Apr 1, 2003 |
325 |
| Valentis licenses PEGylation technology. |
|
|
Feb 1, 2003 |
328 |
| Valentis licenses PEGylation technology. |
|
|
Feb 1, 2003 |
328 |
| Affymetrix hits $70 million clinical payday. (Executive briefing: news, trends & market intelligence for instrument executives). |
|
Brief Article |
Jan 31, 2003 |
174 |
| Isis Pharmaceuticals enters into agreement with Pfizer. |
|
|
Jan 1, 2003 |
465 |
| Ingenium licenses Incyte murine model patents. |
|
|
Jan 1, 2003 |
371 |
| Isis license functional genomics patents to atugen. |
|
|
Jan 1, 2003 |
730 |
| Cambridge Antibody and Dyax expand phage display license. |
|
|
Jan 1, 2003 |
391 |
| Beckman Coulter buys orchid instrument business. (Executive briefing: news, trends & market intelligence for instrument executives). |
|
Brief Article |
Dec 31, 2002 |
171 |
| SPIRE TRANSFERS HEMODIALYSIS CATHETER PATENT LICENSE TO BARD. |
|
|
Dec 1, 2002 |
306 |
| Biotechnology. (Industry Watch). |
|
Brief Article |
Oct 15, 2002 |
164 |
| Affymetrix signs gene expression agreement with Schering-Plough. |
|
Brief Article |
Oct 1, 2002 |
204 |
| Medix licenses Immunomedics' carcinoembryonic antigen technology. |
|
|
Oct 1, 2002 |
449 |
| Neurocrine and Taisho restructure diabetes agreement. |
|
|
Oct 1, 2002 |
424 |
| BioStratum signs kidney disease treatment agreements with Genzyme. |
|
Brief Article |
Sep 1, 2002 |
552 |
| Targeted Genetics expands patent portfolio for program. |
|
Brief Article |
Jun 1, 2002 |
589 |
| Tanox enters licensing agreement for Its cancer gene. |
|
Brief Article |
Jun 1, 2002 |
330 |
| Genetic Technologies licenses genomic mapping patents to Sequenom. |
|
Brief Article |
Apr 1, 2002 |
303 |
| Advanced Cell announces license of its cloning. |
|
Brief Article |
Apr 1, 2002 |
388 |
| Collateral Therapeutics acquires rights to the EPAS1 gene. |
|
Brief Article |
Mar 1, 2002 |
212 |
| Ambion licenses RNA interference technology from MIT. |
|
Brief Article |
Mar 1, 2002 |
226 |
| Cambridge Anitbody Technology gains access to Incyte cDNA clone database. |
|
Brief Article |
Dec 1, 2001 |
539 |
| Millennium in-licenses novel oncology program from Xenova. |
|
|
Dec 1, 2001 |
1231 |
| TriPath earns FDA nod for AutoCyte Prep system screening. (Industry Watch). |
|
Brief Article |
Dec 1, 2001 |
82 |
| Hybridon Announces Early Receipt of $15 Million Payments Under Isis Cross-License Agreement. |
|
|
Nov 15, 2001 |
550 |
| Maxygen and Aventis Pasteur Enter Strategic Alliance to Develop Improved Vaccines. |
|
|
Nov 5, 2001 |
721 |
| Incyte Genomics Signs Exclusive Patent Agreement With Genentech to Enable Commercialization of Therapeutic Antibodies to Four Proteins. |
|
|
Oct 23, 2001 |
544 |
| Incyte Genomics and Epoch Biosciences Enter Into License, Development And Supply Alliance. |
|
|
Oct 10, 2001 |
1004 |
| Lexicon Genetics Licenses Patented Gene Targeting Technology to Pfizer Inc. |
|
|
Oct 10, 2001 |
385 |
| Proteome Systems and Shimadzu Biotech Complete 1st Stage of The Chemical Printer Development. |
|
|
Oct 9, 2001 |
504 |
| NetGenics DiscoveryCenter(TM) Selected by Paradigm Genetics. |
|
|
Oct 1, 2001 |
317 |
| Integrative Proteomics and the University of Toronto Join Efforts to Map Bacterial Proteomes - Knowledge to Fight Infectious Disease. |
|
|
Oct 1, 2001 |
505 |
| Tangerine and ImClone sign oligonucleotide license agreement. |
|
Brief Article |
Sep 1, 2001 |
353 |
| Medigene expands exclusive license for the universal application of herpes simplex virus amplicon technology. |
|
|
Sep 1, 2001 |
440 |
| Physiome Sciences Licenses PathwayPrism(TM) Biological Modeling Technology to 3rd Millennium for the Development of Models for Huntington's Disease. |
|
|
Aug 28, 2001 |
923 |
| Demegen to Collaborate with Dow to Design New Compounds. |
|
|
Aug 27, 2001 |
521 |
| Lexicon Genetics Licenses Patented Gene Targeting Technology To Merck & Co., Inc. |
|
|
Aug 23, 2001 |
347 |
| Cell Genesys Licenses Lentiviral Gene Delivery Technology to Invitrogen For the Research Market. |
|
|
Aug 13, 2001 |
1271 |
| Cell Genesys Licenses Lentiviral Gene Delivery Technology to Invitrogen For the Research Market. |
|
|
Aug 10, 2001 |
1271 |
| Orchid and Affymetrix Expand Genotyping Licensing and Distribution Agreements - Orchid Adds Key Patent to Comprehensive Primer Extension Portfolio -. |
|
|
Aug 7, 2001 |
1363 |
| Corvas International to License Incyte Genomics LifeSeq(R) Gold Database Online. |
|
|
Aug 1, 2001 |
1301 |
| Valentis Licenses GeneSwitch(TM) Technology to Lexicon Genetics for Functional Genomics Research. |
|
|
Aug 1, 2001 |
609 |
| Lexicon licenses patented gene targeting technology to Merck. |
|
Brief Article |
Aug 1, 2001 |
155 |
| GeneMachines(R) Licenses Fundamental Microarray Fabrication Technology From Incyte Genomics, Inc. |
|
|
Jul 23, 2001 |
269 |
| Lexicon Genetics Expands Collaboration With Oriental Yeast Company in Japanese Drug Discovery Market. |
|
|
Jul 10, 2001 |
731 |
| Demegen Licenses Technology for Controlling Pierce's Disease. |
|
|
Jun 4, 2001 |
786 |
| Physiome and University of Connecticut sign license for virtual cell technology. |
|
Brief Article |
Jun 1, 2001 |
477 |
| Lifecodes to Develop HLA Applications on Luminex Technology. |
|
|
Apr 26, 2001 |
897 |
| Millennium and BZL Biologics Announce Agreement To Develop Antibody Therapies Against Key Target In Prostate Cancer. |
|
|
Apr 11, 2001 |
1567 |
| Eisai Co., Ltd. to License Incyte Genomics LifeSeq(R) Gold Online. |
|
|
Apr 9, 2001 |
700 |
| MARKETING NEWS. |
|
Brief Article |
Apr 1, 2001 |
629 |
| Gene Blues. |
THOMPSON, NICHOLAS |
Industry Overview |
Apr 1, 2001 |
3881 |
| Merck licenses gene expression data microarray technology from Incyte. |
|
Brief Article |
Apr 1, 2001 |
258 |
| NeoTherapeutics' NeoGene Signs License Agreement with Pfizer. |
|
|
Mar 19, 2001 |
555 |
| Sangamo BioSciences Licenses Cell-Based Selection System From Massachusetts Institute of Technology and Harvard University. |
|
|
Mar 6, 2001 |
603 |
| Millennium and ImmunoGen Form Multi-Product Antibody Collaboration. |
|
|
Mar 5, 2001 |
1083 |
| Aslera(TM) New Drug Application to Be Reviewed at FDA Advisory Committee Meeting on April 19, 2001. |
|
|
Feb 20, 2001 |
725 |
| Incyte Licenses Comprehensive Microarray Patent Portfolio to Chiron. |
|
|
Jan 11, 2001 |
419 |
| BioMarin Exercises Option to Acquire Exclusive Rights to Proprietary Burn Product Candidate. |
|
|
Jan 11, 2001 |
947 |
| Maxygen Announces Issuance of Additional Patents Covering Methods of Producing Chimeric Genes. |
|
|
Jan 9, 2001 |
504 |
| Dyax Corp. and Human Genome Sciences Enter into Exclusive BLyS Purification License. |
|
|
Jan 8, 2001 |
625 |
| Senomyx(SM), Inc. to License Incyte's Gene Sequence Databases For the Discovery of Genes Involved in Taste and Olfaction. |
|
|
Jan 5, 2001 |
787 |
| Bionova Holding Completes Definitive Agreements With Savia and Wins Shareholder Lawsuit. |
|
|
Jan 5, 2001 |
1403 |
| Affymetrix Grants Genomic Solutions a License to Commercialize Low and Medium Density DNA Arrays. |
|
|
Jan 4, 2001 |
741 |
| Affymetrix and Lexicon Genetics sign Genechip Biotechaccess agreement. |
|
Brief Article |
Jan 1, 2001 |
194 |
| Lexicon Genetics Grants Roche Bioscience Renewal to Technology Sublicense. |
|
|
Dec 19, 2000 |
381 |
| Encore Pharmaceuticals Licenses Lead Cancer Compound to Myriad Genetics. |
|
|
Dec 8, 2000 |
583 |
| Myriad Genetics Acquires Exclusive Rights to Cancer Drug In Phase II Human Clinical Trials. |
|
|
Dec 8, 2000 |
903 |
| Sumitomo Pharmaceuticals to License LifeSeq Gold Online; Online Products Propel Penetration of Japanese Market. |
|
|
Dec 4, 2000 |
682 |
| Genencor signs patent and know how license agreement with Protein Polymer Technologies. |
|
Brief Article |
Dec 1, 2000 |
428 |
| Avigenics obtains rights to license Geron patents for generating cloned poultry. |
|
Brief Article |
Dec 1, 2000 |
325 |
| Sankyo Co Ltd Becomes First Subscriber to LifeSeq Gold Online. |
|
|
Nov 30, 2000 |
712 |
